ποΈ Verified NIH Record β’ Updated 2026-08-11
PULSED AF Post-Approval Study (NCT06578104)
PULSED AF Post-Approval Study, an Addendum to the PulseSelectβ’ PFA Global Registry
π’ Recruiting Interventional Protocol π Observational Clinical Research Sponsor: Medtronic Cardiac Ablation Solutions
π©Ί Plain-English Summary (8th-Grade Level)
PULSED AF PAS is a prospective, global, multi-center, non-randomized, observational trial. Subjects will be treated with the PulseSelectβ’ PFA System and followed through 36 months.
Who can join: Review the eligibility criteria below.
Location: University of South Florida Health (USF) β Tampa, Florida
Age range: 18 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (23 Sites)
- University of South Florida Health (USF) β Tampa, Florida
- Piedmont Heart Institute β Atlanta, Georgia
- Endeavor Health Swedish Hospital β Chicago, Illinois
- Pikeville Medical Center β Whitesburg, Kentucky
- Southcoast Health System β Fall River, Massachusetts
- Beaumont Health System β Royal Oak, Michigan
- Nebraska Medical Center β Omaha, Nebraska
- The Valley Hospital β New York, New York
- Northwell Health Lenox Hill Hospital β New York, New York
- Duke University Medical Center (DUMC) β Durham, North Carolina
- Bethesda North Hospital β Cincinnati, Ohio
- The Ohio State University Wexner Medical Center β Columbus, Ohio
- Mount Carmel Grove City Medical Center β Grove City, Ohio
- Doylestown Health Cardiology a division of Doylestown Health Physicians β Doylestown, Pennsylvania
- AnMed Health Center β Anderson, South Carolina
- Medical University of South Carolina (MUSC) β Charleston, South Carolina
- Texas Health Research & Education Institute β Dallas, Texas
- University of Virginia Medical Center β Charlottesville, Virginia
- Confluence Health Hospital Central Campus β Wenatchee, Washington
- London Health Sciences Centre - University Campus β London, Ontario
- Sunnybrook Health Sciences Centre β Toronto, Ontario
- Montreal Heart Institute β Montreal, Quebec
- Keimyung University Dongsan Hospital β Daegu,
π Contact the Study Coordinator
Phone: (763) 505-0262
Email: josman.suri@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation
- CHAMPION-AF Clinical Trial β Birmingham, Alabama
- Reversal of Atrial Substrate to Prevent Atrial β Calgary, Alberta
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients β Rochester, New York
- REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry β Chandler, Arizona
- Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) β Cleveland, Ohio
- Liraglutide Effect in Atrial Fibrillation β Miami, Florida
Explore by condition: All Atrial Fibrillation clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.